2025年1月13日 · Research & Development at Janssen: innovations which lead to better insights into diseases As far as Janssen is concerned, working on incremental improvements to …

J&J is advancing the next era of medical innovation through our continuous R&D investments, totaling $77.7 billion since 2016. 1 However, patients’ cost exposure and access challenges …

2025年2月28日 · We have carefully selected our applications to support high-priority projects across our R&D pipeline, from Discovery to Clinical Development: Discovery Generating …

“The past is of little interest to me. I am more interested in the present and particularly the future.” Dr Paul Janssen

2025年1月13日 · Janssen in Belgium is not only active in developing medicines — we produce and distribute them as well. Our distribution department plays a key role in Johnson & …

PRODUCT: PREZISTA® 600MG Tblt, 60 Count. NDC: 5967656201; Operating Company: Janssen Products, LP Type: Trade; Case Size: 12; Min Order Qty: 12; Case Weight (lbs). 3 ...

2024年9月26日 · Actelion Specialty Pharmacies. Below are JOM's current Authorized Distributors of Record. Please select the authorized distributors below to see the products that they are …

cardinal health p.r. 120, inc. cardinal health specialty pharmaceutical distribution : cardinal health, inc. cesar castillo, inc. curascript sd specialty distribution division of express scripts (previously …

O exemplo do nosso fundador, Dr. Paul Janssen, continua a estar no centro de tudo o que fazemos para combater a doença e melhorar a vida dos doentes.

2024年9月24日 · Johnson & Johnson（法人名：ヤンセンファーマ株式会社、本社：東京都千代田区、代表取締役社長：關口修平、以下「J&J」）は24日、エンドセリン受容体拮抗薬マシ …